HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liebwin Gossner Selected Research

Neoplasms (Cancer)

4/2016Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II).
6/2013Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion.
10/2008Early Barrett's carcinoma with "low-risk" submucosal invasion: long-term results of endoscopic resection with a curative intent.
6/2007Conclusions from the histological diagnosis of low-grade intraepithelial neoplasia in Barrett's oesophagus.
3/2007Prospective evaluation of a new high-power argon plasma coagulation system (hp-APC) in therapeutic gastrointestinal endoscopy.
10/2006The impact of endoscopic ultrasound and computed tomography on the TNM staging of early cancer in Barrett's esophagus.
8/2006In vivo histology of Barrett's esophagus and associated neoplasia by confocal laser endomicroscopy.
7/2005Long-term results of photodynamic therapy with 5-aminolevulinic acid for superficial Barrett's cancer and high-grade intraepithelial neoplasia.
7/2004Endoscopic resection of superficial esophageal squamous-cell carcinomas: Western experience.
2/2004Management of pre-malignant and malignant lesions by endoscopic resection.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Liebwin Gossner Research Topics

Disease

15Neoplasms (Cancer)
04/2016 - 06/2002
5Barrett Esophagus (Barrett's Esophagus)
03/2007 - 07/2005
4Carcinoma (Carcinomatosis)
03/2007 - 06/2002
4Adenocarcinoma
01/2007 - 06/2002
3Hemorrhage
10/2008 - 10/2002
2Esophageal Neoplasms (Esophageal Cancer)
03/2007 - 08/2003
2Body Weight (Weight, Body)
07/2005 - 06/2002
1Abscess
10/2021
1Eosinophilic Esophagitis
10/2021
1Stomach Neoplasms (Stomach Cancer)
03/2009
1Neoplasm Metastasis (Metastasis)
10/2008
1Zenker Diverticulum (Zenker's Diverticulum)
03/2007
1Polyps
03/2007
1Adenoma (Adenomas)
03/2007
1Angiodysplasia
03/2007
1Esophageal Stenosis (Esophageal Stricture)
07/2004
1Squamous Cell Neoplasms (Squamous Cell Cancer)
07/2004
1Carcinoma in Situ
07/2004
1Ulcer
08/2003
1Pathologic Constriction (Stenosis)
10/2002
1Sunburn
10/2002
1Thymic aplasia
06/2002

Drug/Important Bio-Agent (IBA)

41-phenyl-3,3-dimethyltriazene (PDT)IBA
07/2005 - 06/2002
2Photosensitizing Agents (Photosensitizers)IBA
07/2005 - 06/2002
2protoporphyrin IXIBA
07/2005 - 06/2002
2AcidsIBA
07/2005 - 06/2002
1Anti-Bacterial Agents (Antibiotics)IBA
10/2021
1Budesonide (Pulmicort)FDA LinkGeneric
10/2021
1Hemoglobins (Hemoglobin)IBA
10/2008
1A 19IBA
07/2004

Therapy/Procedure

15Therapeutics
10/2021 - 10/2002
3Esophagectomy
07/2005 - 07/2003
2Lasers (Laser)
08/2006 - 06/2002
2Photochemotherapy (Photodynamic Therapy)
07/2005 - 06/2002
1Remission Induction
10/2021
1Radiofrequency Ablation
04/2016
1Palliative Care (Palliative Therapy)
03/2007
1Solid-State Lasers
03/2007
1Oral Administration
07/2005
1Blood Transfusion (Blood Transfusions)
07/2004
1Chemoradiotherapy
07/2004
1Ligation
08/2003